HEADER MEMBRANE PROTEIN 06-APR-22 7UM4 TITLE CRYSTAL STRUCTURE OF INACTIVE 5-HT5AR IN COMPLEX WITH AS2674723 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5-HYDROXYTRYPTAMINE RECEPTOR 5A; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: 5-HT-5,5-HT-5A,5-HT5A,SEROTONIN RECEPTOR 5A; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PGS; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HTR5A; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 14 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS GPCR, INACTIVE STATE, MEMBRANE PROTEIN, 5-HT5AR, HTR5A EXPDTA X-RAY DIFFRACTION AUTHOR S.ZHANG,B.L.ROTH REVDAT 3 18-OCT-23 7UM4 1 REMARK REVDAT 2 27-JUL-22 7UM4 1 JRNL REVDAT 1 20-JUL-22 7UM4 0 JRNL AUTH S.ZHANG,H.CHEN,C.ZHANG,Y.YANG,P.POPOV,J.LIU,B.E.KRUMM,C.CAO, JRNL AUTH 2 K.KIM,Y.XIONG,V.KATRITCH,B.K.SHOICHET,J.JIN,J.F.FAY,B.L.ROTH JRNL TITL INACTIVE AND ACTIVE STATE STRUCTURES TEMPLATE SELECTIVE JRNL TITL 2 TOOLS FOR THE HUMAN 5-HT 5A RECEPTOR. JRNL REF NAT.STRUCT.MOL.BIOL. V. 29 677 2022 JRNL REFN ESSN 1545-9985 JRNL PMID 35835867 JRNL DOI 10.1038/S41594-022-00796-6 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.73 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 13698 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.231 REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.960 REMARK 3 FREE R VALUE TEST SET COUNT : 680 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.7300 - 4.7900 0.99 2802 137 0.2089 0.2522 REMARK 3 2 4.7900 - 3.8000 1.00 2651 152 0.2102 0.2321 REMARK 3 3 3.8000 - 3.3200 1.00 2648 132 0.2488 0.3120 REMARK 3 4 3.3200 - 3.0200 0.99 2598 129 0.2670 0.3435 REMARK 3 5 3.0200 - 2.8000 0.89 2319 130 0.3125 0.3668 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.460 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.130 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 68.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 67.55 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7UM4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-APR-22. REMARK 100 THE DEPOSITION ID IS D_1000262095. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-AUG-19 REMARK 200 TEMPERATURE (KELVIN) : 80 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13732 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.30700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 1.02400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4S0V, 4IAR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM CHLORIDE, 0.1 M LITHIUM REMARK 280 SULFATE, 0.1 M DL-MALIC ACID PH 5.9, 30 % V/V PEG 400, LIPIDIC REMARK 280 CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 67.64450 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 21.23000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 67.64450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 21.23000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 22 REMARK 465 SER A 23 REMARK 465 LEU A 24 REMARK 465 GLY A 25 REMARK 465 LYS A 26 REMARK 465 ASP A 27 REMARK 465 ASP A 28 REMARK 465 LEU A 29 REMARK 465 ARG A 30 REMARK 465 PRO A 31 REMARK 465 SER A 32 REMARK 465 SER A 33 REMARK 465 PRO A 34 REMARK 465 ARG A 67 REMARK 465 VAL A 68 REMARK 465 ARG A 69 REMARK 465 THR A 70 REMARK 465 PHE A 71 REMARK 465 HIS A 72 REMARK 465 ARG A 73 REMARK 465 VAL A 74 REMARK 465 GLY A 232 REMARK 465 SER A 233 REMARK 465 ARG A 234 REMARK 465 LYS A 235 REMARK 465 THR A 236 REMARK 465 ASN A 237 REMARK 465 SER A 238 REMARK 465 VAL A 239 REMARK 465 SER A 240 REMARK 465 PRO A 241 REMARK 465 ILE A 242 REMARK 465 SER A 243 REMARK 465 GLU A 244 REMARK 465 ALA A 245 REMARK 465 VAL A 246 REMARK 465 GLU A 247 REMARK 465 VAL A 248 REMARK 465 LYS A 249 REMARK 465 ASP A 250 REMARK 465 SER A 251 REMARK 465 ALA A 252 REMARK 465 LYS A 253 REMARK 465 GLN A 254 REMARK 465 PRO A 255 REMARK 465 GLN A 256 REMARK 465 MET A 257 REMARK 465 VAL A 258 REMARK 465 PHE A 259 REMARK 465 THR A 260 REMARK 465 VAL A 261 REMARK 465 ARG A 262 REMARK 465 HIS A 263 REMARK 465 ALA A 264 REMARK 465 THR A 265 REMARK 465 VAL A 266 REMARK 465 THR A 267 REMARK 465 PHE A 268 REMARK 465 GLN A 269 REMARK 465 PRO A 270 REMARK 465 GLU A 271 REMARK 465 GLY A 272 REMARK 465 ASP A 273 REMARK 465 THR A 274 REMARK 465 TRP A 275 REMARK 465 ARG A 276 REMARK 465 ASN A 342 REMARK 465 LYS A 343 REMARK 465 ASN A 344 REMARK 465 TYR A 345 REMARK 465 ASN A 346 REMARK 465 SER A 347 REMARK 465 ALA A 348 REMARK 465 PHE A 349 REMARK 465 LYS A 350 REMARK 465 ASN A 351 REMARK 465 PHE A 352 REMARK 465 PHE A 353 REMARK 465 SER A 354 REMARK 465 ARG A 355 REMARK 465 GLN A 356 REMARK 465 HIS A 357 REMARK 465 GLY B 1001 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 108 CG CD OE1 NE2 REMARK 470 ARG A 145 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 148 CG CD OE1 OE2 REMARK 470 PHE A 179 CG CD1 CD2 CE1 CE2 CZ REMARK 470 TRP A 221 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 221 CZ3 CH2 REMARK 470 CYS A 311 SG REMARK 470 ASP A 314 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 145 37.74 -97.34 REMARK 500 TYR A 149 58.82 -96.72 REMARK 500 LEU A 174 50.16 -92.72 REMARK 500 GLU A 191 148.21 -170.10 REMARK 500 CYS A 311 -19.37 92.73 REMARK 500 ASP A 314 22.21 -146.35 REMARK 500 ASP B1117 -7.00 68.66 REMARK 500 PRO B1122 48.23 -79.97 REMARK 500 THR B1155 -168.45 -117.65 REMARK 500 REMARK 500 REMARK: NULL DBREF 7UM4 A 22 357 UNP P47898 5HT5A_HUMAN 22 357 DBREF 7UM4 B 1001 1200 PDB 7UM4 7UM4 1001 1200 SEQADV 7UM4 ASN A 86 UNP P47898 ASP 86 ENGINEERED MUTATION SEQADV 7UM4 ALA A 299 UNP P47898 ILE 299 ENGINEERED MUTATION SEQRES 1 A 336 HIS SER LEU GLY LYS ASP ASP LEU ARG PRO SER SER PRO SEQRES 2 A 336 LEU LEU SER VAL PHE GLY VAL LEU ILE LEU THR LEU LEU SEQRES 3 A 336 GLY PHE LEU VAL ALA ALA THR PHE ALA TRP ASN LEU LEU SEQRES 4 A 336 VAL LEU ALA THR ILE LEU ARG VAL ARG THR PHE HIS ARG SEQRES 5 A 336 VAL PRO HIS ASN LEU VAL ALA SER MET ALA VAL SER ASN SEQRES 6 A 336 VAL LEU VAL ALA ALA LEU VAL MET PRO LEU SER LEU VAL SEQRES 7 A 336 HIS GLU LEU SER GLY ARG ARG TRP GLN LEU GLY ARG ARG SEQRES 8 A 336 LEU CYS GLN LEU TRP ILE ALA CYS ASP VAL LEU CYS CYS SEQRES 9 A 336 THR ALA SER ILE TRP ASN VAL THR ALA ILE ALA LEU ASP SEQRES 10 A 336 ARG TYR TRP SER ILE THR ARG HIS MET GLU TYR THR LEU SEQRES 11 A 336 ARG THR ARG LYS CYS VAL SER ASN VAL MET ILE ALA LEU SEQRES 12 A 336 THR TRP ALA LEU SER ALA VAL ILE SER LEU ALA PRO LEU SEQRES 13 A 336 LEU PHE GLY TRP GLY GLU THR TYR SER GLU GLY SER GLU SEQRES 14 A 336 GLU CYS GLN VAL SER ARG GLU PRO SER TYR ALA VAL PHE SEQRES 15 A 336 SER THR VAL GLY ALA PHE TYR LEU PRO LEU CYS VAL VAL SEQRES 16 A 336 LEU PHE VAL TYR TRP LYS ILE TYR LYS ALA ALA LYS PHE SEQRES 17 A 336 ARG VAL GLY SER ARG LYS THR ASN SER VAL SER PRO ILE SEQRES 18 A 336 SER GLU ALA VAL GLU VAL LYS ASP SER ALA LYS GLN PRO SEQRES 19 A 336 GLN MET VAL PHE THR VAL ARG HIS ALA THR VAL THR PHE SEQRES 20 A 336 GLN PRO GLU GLY ASP THR TRP ARG GLU GLN LYS GLU GLN SEQRES 21 A 336 ARG ALA ALA LEU MET VAL GLY ILE LEU ILE GLY VAL PHE SEQRES 22 A 336 VAL LEU CYS TRP ALA PRO PHE PHE LEU THR GLU LEU ILE SEQRES 23 A 336 SER PRO LEU CYS SER CYS ASP ILE PRO ALA ILE TRP LYS SEQRES 24 A 336 SER ILE PHE LEU TRP LEU GLY TYR SER ASN SER PHE PHE SEQRES 25 A 336 ASN PRO LEU ILE TYR THR ALA PHE ASN LYS ASN TYR ASN SEQRES 26 A 336 SER ALA PHE LYS ASN PHE PHE SER ARG GLN HIS SEQRES 1 B 200 GLY SER HIS ASN GLY ILE ASP CYS SER PHE TRP ASN GLU SEQRES 2 B 200 SER TYR LEU THR GLY SER ARG ASP GLU ARG LYS LYS SER SEQRES 3 B 200 LEU LEU SER LYS PHE GLY MET ASP GLU GLY VAL THR PHE SEQRES 4 B 200 MET PHE ILE GLY ARG PHE ASP ARG GLY GLN LYS GLY VAL SEQRES 5 B 200 ASP VAL LEU LEU LYS ALA ILE GLU ILE LEU SER SER LYS SEQRES 6 B 200 LYS GLU PHE GLN GLU MET ARG PHE ILE ILE ILE GLY LYS SEQRES 7 B 200 GLY ASP PRO GLU LEU GLU GLY TRP ALA ARG SER LEU GLU SEQRES 8 B 200 GLU LYS HIS GLY ASN VAL LYS VAL ILE THR GLU MET LEU SEQRES 9 B 200 SER ARG GLU PHE VAL ARG GLU LEU TYR GLY SER VAL ASP SEQRES 10 B 200 PHE VAL ILE ILE PRO SER TYR PHE GLU PRO PHE GLY LEU SEQRES 11 B 200 VAL ALA LEU GLU ALA MET CYS LEU GLY ALA ILE PRO ILE SEQRES 12 B 200 ALA SER ALA VAL GLY GLY LEU ARG ASP ILE ILE THR ASN SEQRES 13 B 200 GLU THR GLY ILE LEU VAL LYS ALA GLY ASP PRO GLY GLU SEQRES 14 B 200 LEU ALA ASN ALA ILE LEU LYS ALA LEU GLU LEU SER ARG SEQRES 15 B 200 SER ASP LEU SER LYS PHE ARG GLU ASN CYS LYS LYS ARG SEQRES 16 B 200 ALA MET SER PHE SER HET PGE A1601 10 HET PEG A1602 7 HET PG4 A1603 13 HET PEG A1604 7 HET 1PE A1605 16 HET PEG A1606 7 HET NN6 A1607 26 HETNAM PGE TRIETHYLENE GLYCOL HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM 1PE PENTAETHYLENE GLYCOL HETNAM NN6 ~{N}-[AZANYL(AZANYLIDENE)METHYLIDENE]-5-FLUORANYL-8-[2, HETNAM 2 NN6 4,6-TRIS(FLUORANYL)PHENYL]-3,4-DIHYDRO-1~{H}- HETNAM 3 NN6 ISOQUINOLINE-2-CARBOXAMIDE HETSYN 1PE PEG400 FORMUL 3 PGE C6 H14 O4 FORMUL 4 PEG 3(C4 H10 O3) FORMUL 5 PG4 C8 H18 O5 FORMUL 7 1PE C10 H22 O6 FORMUL 9 NN6 C17 H14 F4 N4 O FORMUL 10 HOH *8(H2 O) HELIX 1 AA1 LEU A 36 LEU A 66 1 31 HELIX 2 AA2 HIS A 76 GLU A 101 1 26 HELIX 3 AA3 GLY A 110 THR A 144 1 35 HELIX 4 AA4 THR A 150 LEU A 174 1 25 HELIX 5 AA5 LEU A 174 PHE A 179 1 6 HELIX 6 AA6 GLU A 197 PHE A 209 1 13 HELIX 7 AA7 PHE A 209 LYS A 228 1 20 HELIX 8 AA8 GLN A 278 SER A 308 1 31 HELIX 9 AA9 PRO A 316 SER A 329 1 14 HELIX 10 AB1 SER A 329 THR A 339 1 11 HELIX 11 AB2 ASN B 1012 LEU B 1016 5 5 HELIX 12 AB3 SER B 1019 LYS B 1030 1 12 HELIX 13 AB4 GLY B 1051 SER B 1063 1 13 HELIX 14 AB5 SER B 1064 GLN B 1069 5 6 HELIX 15 AB6 ASP B 1080 HIS B 1094 1 15 HELIX 16 AB7 SER B 1105 ASP B 1117 1 13 HELIX 17 AB8 GLY B 1129 CYS B 1137 1 9 HELIX 18 AB9 VAL B 1147 ILE B 1154 1 8 HELIX 19 AC1 ASP B 1166 LEU B 1180 1 15 HELIX 20 AC2 ASP B 1184 SER B 1198 1 15 SHEET 1 AA1 3 VAL B1037 ILE B1042 0 SHEET 2 AA1 3 MET B1071 ILE B1076 1 O ILE B1074 N PHE B1041 SHEET 3 AA1 3 VAL B1097 ILE B1100 1 O LYS B1098 N PHE B1073 SHEET 1 AA2 3 PHE B1118 ILE B1121 0 SHEET 2 AA2 3 ILE B1141 SER B1145 1 O ILE B1143 N VAL B1119 SHEET 3 AA2 3 ILE B1160 VAL B1162 1 O ILE B1160 N ALA B1144 SSBOND 1 CYS A 114 CYS A 192 1555 1555 2.04 CRYST1 135.289 42.460 94.787 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007392 0.000000 0.000000 0.00000 SCALE2 0.000000 0.023552 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010550 0.00000